Efficacy of a novel vaccine in an atrophic rhinitis-infected farm

Inicio Conocimiento Efficacy of a novel vaccine in an atrophic rhinitis-infected farm

Efficacy of a novel vaccine in an atrophic rhinitis-infected farm

The aim of this study was to assess the efficacy of RHINISENG® in a commercial pig farm in China. 

Sobre este artículo

Apareció en

IPVS Congress China, 2018

Fecha

12 jul. 2018

Autores

Ning, H.; Zhou, K.; Wang, P.; Wu, M.H.; Martos, A.

Resumen

Results in this study showed that pregnant sows vaccinated with RHINISENG® can effectively reduce nasal lesions and drug costs, improve the feed conversion rate (FCR) and bring good ROi.

Productos relacionados

Compartir en